000			02176nam a22003618a 4500
005			20250918140545.0
008			110426s2011 njua b 001 0 eng
020			_a9780470504789 (hbk.) _cRM312.90
039		9	_a201106281641 _brosli _c201106151516 _drahah _c201104261538 _drahah _y04-26-2011 _zrahah
040			_aUKM
090			_aQP529.B536
090			_aQP529 _b.B536
245	0	0	_aBiotransformation and metabolite elucidation of xenobiotics / _cedited by Ala F. Nassar.
260			_aHoboken, N.J. : _bJohn Wiley & Sons, _cc2011.
300			_axi, 328 p. : _bill. ; _c25 cm.
504			_aIncludes bibliographical references and index.
505	0		_aHuman biotransformation / Andrew Parkinson -- Analytical tools and approaches for metabolite identification in drug metabolism / Yongmei Li -- Tools of choice for accelerating metabolite identification : mass spec technology drives metabolite identification studies forward / Ala Nassar -- Improving drug design : considerations for the structural modification process / Ala Nassar -- Case study : the unanticipated loss of N2 from novel dna alkylating agent laromustine by collision-induced dissociation : novel rearrangements / Ala Nassar, Tukiet T. Lam -- Case study : identification of in vitro metabolite/decomposition products of the novel DNA alkylating agent laromustine / Ala Nassar, TuKiet T. Lam -- Strategies for the detection of reactive intermediates in drug discovery and development / Mark P. Grillo -- Safety testing of drug metabolites : MIST guidance impact on the practice of industrial drug metabolism / J. Greg Slatter.
650		0	_aXenobiotics _xMetabolism.
650		0	_aMetabolites _xIdentification.
650		0	_aBiotransformation (Metabolism)
650	1	2	_aXenobiotics _xmetabolism.
650	1	2	_aXenobiotics _xpharmacology.
650	2	2	_aBiotransformation _xphysiology.
650	2	2	_aDrug Discovery.
700	1		_aNassar, Ala F.
907			_a.b15019858 _b2021-05-28 _c2019-11-12
942			_c01 _n0 _kQP529.B536
914			_avtls003464237
990			_ark4
991			_aFakulti Sains & Teknologi
998			_at _b2011-01-04 _cm _da _feng _gnju _y0 _z.b15019858
999			_c486704 _d486704